Google's smart contact lens, that can measure blood sugar level, is on its way to be commercialized with the tech giant collaborating with Novartis to develop it.
According to The Verge, the lens which was developed and unveiled by Google X in January, analyzes tear fluid in the eye using non-invasive sensors to measure a person's blood glucose levels constantly. The results can also be sent to any mobile phone wirelessly.
The product is expected to help diabetic patients in managing the disease. Novartis has already licensed the technology through Alcon, its eye-care subsidiary, and will soon start developing the product for commercial use, the report said.
By implanting the lens directly into the eye, the technology can also be used to fix eye's natural autofocus, Novartis added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
